[96a5a0]: / output / allTrials / identified / NCT05186948_identified.json

Download this file

480 lines (480 with data), 20.9 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
{
"info": {
"nct_id": "NCT05186948",
"official_title": "Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI)",
"inclusion_criteria": "* For all participants:\n\n 1. Able to provide informed consent.\n 2. Visual acuity sufficient to be able to read the consent form with corrective lenses.\n 3. Over 18 years of age.\n 4. English- or French-speaking.\n* For patients only:\n\n 1. Initial diagnosis of breast cancer stage I-IIIA and scheduled chemotherapy\n 2. First-time cancer diagnosis.\n 3. ECOG performance < 2\n 4. Receiving curative intent chemotherapy: either Adriamycin/Cyclophosphamide for 4 cycles followed by weekly Taxol for 12 cycles or Taxotere/Cyclophosphamide for 4 cycles\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "* For all participants:\n\n 1. Evidence or medical history of neurological/psychiatric issues known to affect movements and oculomotor control.\n 2. Presence of comorbid neurological conditions to avoid eye movement anomaly confounds (Strabismus, cranial nerve palsy, stroke-causing hemianopsia).\n 3. Diagnosis of macular edema or other pre-existing ocular conditions that would prevent participants from performing the eye movement assessments.\n 4. Previous history of cancer or chemotherapy\n 5. Distant metastases\n 6. Recent (less than three months from enrollment) start of, change of dose, or irregular use of, new prescription drugs known to influence ocular motor visual function, such as benzodiazepines, antipsychotics and anticonvulsants. Occasional use of benzodiazepines for medical procedures is permitted, at the investigator's discretion, but should not occur within a short time period prior to or during an eye movement assessment.\n 7. Diagnosis of a substance abuse disorder.\n 8. Recreational drug use (e.g., alcohol, marijuana) is a potential exclusion criterion that will be determined on an individual basis as per the discretion of the research team. All recreational drug use will be documented.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "1. Able to provide informed consent.",
"criterions": [
{
"exact_snippets": "Able to provide informed consent.",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "2. Visual acuity sufficient to be able to read the consent form with corrective lenses.",
"criterions": [
{
"exact_snippets": "Visual acuity sufficient to be able to read the consent form with corrective lenses.",
"criterion": "visual acuity",
"requirements": [
{
"requirement_type": "sufficiency",
"expected_value": "able to read the consent form with corrective lenses"
}
]
}
]
},
{
"line": "3. Over 18 years of age.",
"criterions": [
{
"exact_snippets": "Over 18 years of age.",
"criterion": "age",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "4. English- or French-speaking.",
"criterions": [
{
"exact_snippets": "English- or French-speaking",
"criterion": "language",
"requirements": [
{
"requirement_type": "language",
"expected_value": [
"English",
"French"
]
}
]
}
]
},
{
"line": "* For patients only:",
"criterions": [
{
"exact_snippets": "patients only",
"criterion": "patient status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "patient"
}
]
}
]
},
{
"line": "1. Initial diagnosis of breast cancer stage I-IIIA and scheduled chemotherapy",
"criterions": [
{
"exact_snippets": "Initial diagnosis of breast cancer",
"criterion": "breast cancer",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
},
{
"exact_snippets": "stage I-IIIA",
"criterion": "breast cancer stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 1,
"unit": "stage"
},
{
"operator": "<=",
"value": 3,
"unit": "stage"
}
]
}
}
]
},
{
"exact_snippets": "scheduled chemotherapy",
"criterion": "chemotherapy",
"requirements": [
{
"requirement_type": "schedule",
"expected_value": true
}
]
}
]
},
{
"line": "2. First-time cancer diagnosis.",
"criterions": [
{
"exact_snippets": "First-time cancer diagnosis",
"criterion": "cancer diagnosis",
"requirements": [
{
"requirement_type": "occurrence",
"expected_value": "first-time"
}
]
}
]
},
{
"line": "3. ECOG performance < 2",
"criterions": [
{
"exact_snippets": "ECOG performance < 2",
"criterion": "ECOG performance",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": "<",
"value": 2,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "4. Receiving curative intent chemotherapy: either Adriamycin/Cyclophosphamide for 4 cycles followed by weekly Taxol for 12 cycles or Taxotere/Cyclophosphamide for 4 cycles",
"criterions": [
{
"exact_snippets": "Receiving curative intent chemotherapy: either Adriamycin/Cyclophosphamide for 4 cycles followed by weekly Taxol for 12 cycles or Taxotere/Cyclophosphamide for 4 cycles",
"criterion": "curative intent chemotherapy",
"requirements": [
{
"requirement_type": "regimen",
"expected_value": [
"Adriamycin/Cyclophosphamide for 4 cycles followed by weekly Taxol for 12 cycles",
"Taxotere/Cyclophosphamide for 4 cycles"
]
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "1. Evidence or medical history of neurological/psychiatric issues known to affect movements and oculomotor control.",
"criterions": [
{
"exact_snippets": "Evidence or medical history of neurological/psychiatric issues",
"criterion": "neurological/psychiatric issues",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "known to affect movements",
"criterion": "issues affecting movements",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "known to affect ... oculomotor control",
"criterion": "issues affecting oculomotor control",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "2. Presence of comorbid neurological conditions to avoid eye movement anomaly confounds (Strabismus, cranial nerve palsy, stroke-causing hemianopsia).",
"criterions": [
{
"exact_snippets": "Presence of comorbid neurological conditions",
"criterion": "comorbid neurological conditions",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Strabismus",
"criterion": "Strabismus",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "cranial nerve palsy",
"criterion": "cranial nerve palsy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "stroke-causing hemianopsia",
"criterion": "stroke-causing hemianopsia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "3. Diagnosis of macular edema or other pre-existing ocular conditions that would prevent participants from performing the eye movement assessments.",
"criterions": [
{
"exact_snippets": "Diagnosis of macular edema",
"criterion": "macular edema",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "other pre-existing ocular conditions that would prevent participants from performing the eye movement assessments",
"criterion": "pre-existing ocular conditions",
"requirements": [
{
"requirement_type": "impact on eye movement assessments",
"expected_value": "prevent participants from performing"
}
]
}
]
},
{
"line": "4. Previous history of cancer or chemotherapy",
"criterions": [
{
"exact_snippets": "Previous history of cancer",
"criterion": "history of cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Previous history of ... chemotherapy",
"criterion": "history of chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "5. Distant metastases",
"criterions": [
{
"exact_snippets": "Distant metastases",
"criterion": "distant metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "6. Recent (less than three months from enrollment) start of, change of dose, or irregular use of, new prescription drugs known to influence ocular motor visual function, such as benzodiazepines, antipsychotics and anticonvulsants. Occasional use of benzodiazepines for medical procedures is permitted, at the investigator's discretion, but should not occur within a short time period prior to or during an eye movement assessment.",
"criterions": [
{
"exact_snippets": "Recent (less than three months from enrollment) start of, change of dose, or irregular use of, new prescription drugs known to influence ocular motor visual function",
"criterion": "use of new prescription drugs",
"requirements": [
{
"requirement_type": "time since start/change/irregular use",
"expected_value": {
"operator": "<",
"value": 3,
"unit": "months"
}
},
{
"requirement_type": "influence on ocular motor visual function",
"expected_value": true
}
]
},
{
"exact_snippets": "Occasional use of benzodiazepines for medical procedures is permitted, at the investigator's discretion, but should not occur within a short time period prior to or during an eye movement assessment",
"criterion": "occasional use of benzodiazepines",
"requirements": [
{
"requirement_type": "permitted",
"expected_value": true
},
{
"requirement_type": "timing relative to eye movement assessment",
"expected_value": "should not occur within a short time period prior to or during"
}
]
}
]
},
{
"line": "7. Diagnosis of a substance abuse disorder.",
"criterions": [
{
"exact_snippets": "Diagnosis of a substance abuse disorder",
"criterion": "substance abuse disorder",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
}
]
},
{
"line": "8. Recreational drug use (e.g., alcohol, marijuana) is a potential exclusion criterion that will be determined on an individual basis as per the discretion of the research team. All recreational drug use will be documented.",
"criterions": [
{
"exact_snippets": "Recreational drug use (e.g., alcohol, marijuana) ... potential exclusion criterion",
"criterion": "recreational drug use",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "All recreational drug use will be documented.",
"criterion": "recreational drug use",
"requirements": [
{
"requirement_type": "documentation",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "* For all participants:",
"criterions": []
}
],
"failed_exclusion": [
{
"line": "* For all participants:",
"criterions": []
}
],
"failed_miscellaneous": []
}